Fidelity Advisor Health Care Fund Class A
FACDX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Fidelity Advisor Health Care Fund Class A (FACDX) is an open-end mutual fund that seeks capital appreciation by investing primarily in equity securities of companies engaged in the health care sector; including domestic and foreign issuers involved in medical equipment, supplies, pharmaceuticals, biotechnology, health care services, and life sciences tools; as well as some allocation to bonds and cash equivalents. The fund, domiciled in the United States and available for sale to U.S. investors, normally maintains a portfolio with over 90% in U.S. stocks and approximately 96.64% in the health care sector, targeting mid-cap growth stocks among issuers such as Boston Scientific Corp., UnitedHealth Group Inc., Danaher Corp., Penumbra Inc., and Eli Lilly and Co., which comprise about 30% of assets. Managed by Edward Yoon since October 2008, with support from Fidelity's health care sector team, the fund features a net expense ratio of 0.93%, a 5.75% front-end load, and total net assets of $3.35 billion, including $1.17 billion in the Class A share class. Launched on September 3, 1996, the fund operates under Fidelity Investments, headquartered at 245 Summer Street, Boston, Massachusetts. It serves individual and institutional investors seeking exposure to the health care industry, with geographic focus predominantly in the United States (90.12% of assets), supplemented by positions in the Eurozone, Europe ex-Eurozone, and Canada. Fidelity Investments, the fund's sponsor, maintains a broad platform of mutual funds across asset classes, with FACDX categorized by Morningstar in the Health sector. Recent developments include ongoing portfolio adjustments reflecting market dynamics in health care, such as shifts in top holdings amid volatility in holdings like UnitedHealth Group and Eli Lilly during 2024-2025; alongside Fidelity's broader 2025 retiree health care cost estimate highlighting sector cost pressures. No major mergers, acquisitions, or strategic reorganizations specific to FACDX have been reported in the last 1-2 years, though Fidelity continues to refine its Advisor fund lineup through class launches and sector-focused management enhancements. The fund maintains stable leadership with Edward Yoon as portfolio manager, supported by Fidelity's deep analytical resources in health care equipment, supplies, and biotech coverage.